S

Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506

Watchlist Manager
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Watchlist
Price: 219.2 CNY 7.93% Market Closed
Market Cap: 87.9B CNY
Have any thoughts about
Sichuan Biokin Pharmaceutical Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

19.2
Current
-60.4
Median
13.3
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
19.2
=
Enterprise Value
76.5B CNY
/
EBITDA
4.3B CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
17.7
2-Years Forward
EV/EBITDA
-433
3-Years Forward
EV/EBITDA
-79.5

See Also

Discover More